30/07/2026
GRANIVEX Drops are an advanced antiemetic formulation designed to provide effective prevention and control of nausea and vomiting while supporting improved patient comfort during medical treatments. Formulated with Granisetron 1 mg, a selective 5-HT₃ receptor antagonist, it helps block serotonin-mediated emetic pathways, providing rapid and reliable relief from nausea and vomiting with a convenient oral drop formulation.
Key Benefits
🔹 Antiemetic Care with Trusted 5-HT₃ Blockade
Granisetron selectively blocks 5-HT₃ receptors, providing effective prevention and control of nausea and vomiting associated with various medical conditions and treatments.
🔹 Provides Effective Control of Nausea & Vomiting
Helps prevent and relieve nausea and vomiting caused by chemotherapy, radiotherapy, surgery, and certain medications, improving patient comfort and treatment adherence.
🔹 Rapid & Reliable Antiemetic Action
The oral drop formulation ensures convenient administration with dependable antiemetic efficacy for both pediatric and adult patients, as clinically indicated.
🔹 Supports Better Treatment Tolerance
Helps reduce treatment-related gastrointestinal discomfort, enabling patients to better tolerate chemotherapy, radiotherapy, and post-operative recovery.
🔹 Comprehensive Support for Antiemetic Care
Useful in chemotherapy-induced nausea and vomiting, radiotherapy-induced nausea, post-operative nausea and vomiting, and severe drug-induced nausea, helping improve overall quality of care.
Therapeutic Uses
• Chemotherapy-Induced Nausea & Vomiting (CINV)
• Radiotherapy-Induced Nausea
• Post-Operative Nausea & Vomiting (PONV)
• Severe Drug-Induced Nausea
Reference
National Comprehensive Cancer Network (NCCN). Clinical Practice Guidelines in Oncology: Antiemesis. 2024.
📌 Disclaimer:
This product is intended for use under strict medical supervision only. The information provided is for educational purposes and is not intended for promotional use.